Cite
HARVARD Citation
Oshiro, Y. et al. (2021). Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan. Clinical and translational radiation oncology. pp. 54-59. [Online].